Most notably, compared to tumors with wild-type p53, cancers with TP53 alterations show a very specific pattern of decreased lipid glycerophosphocholines that is not apparent when classifying the cancers by ER status, (Figure S5 in Additional file 4). This evidence concerns the gene TP53 and cancer.